• Study on the Safety and Effects of Losmapimod for Patients with Facioscapulohumeral Muscular Dystrophy 1 (FSHD1)

    Not recruiting

    2 1 1
    The Netherlands
  • Study on OM-85 for Preventing Respiratory Infections in Children with Wheezing Illness (Ages 6 Months to 5 Years)

    Not recruiting

    3 1 1
    Germany Hungary Italy Poland
  • Long-Term Study of Ritlecitinib Tosilate for Adults and Adolescents with Alopecia Areata

    Not recruiting

    3 1 1
    Investigated diseases:
    Czechia Germany Poland Spain
  • Study of Disitamab Vedotin and Pembrolizumab for Patients with Untreated Advanced Urothelial Cancer Expressing HER2

    Not recruiting

    3 1 1 1
    Austria Belgium Czechia France Greece Hungary +7
  • Study of Pirtobrutinib, Venetoclax and Rituximab combination compared to Venetoclax and Rituximab in previously treated Chronic Lymphocytic Leukemia patients

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Belgium Czechia Denmark France Germany Hungary +5
  • Study on Denosumab for Improving Semen Quality in Men with Non-Obstructive Azoospermia

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Denmark
  • Study for Patients with cMET-Dependent Cancers to Continue Treatment with Capmatinib, Nazartinib, and Gefitinib

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Belgium Germany Italy
  • Study of Gilteritinib and Azacitidine for Newly Diagnosed Acute Myeloid Leukemia with FLT3 Mutation in Patients Not Eligible for Intensive Chemotherapy

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Belgium Germany
  • Study on the Effectiveness and Safety of Ralinepag for Patients with Pulmonary Arterial Hypertension

    Not recruiting

    3 1
    Investigated diseases:
    Austria Belgium Bulgaria Czechia Denmark France +9
  • Study on Riliprubart for Preventing and Treating Antibody-Mediated Rejection in Adult Kidney Transplant Patients

    Not recruiting

    2 1 1
    Investigated diseases:
    France Germany Italy Spain Sweden

powered by